(Q43235426)

English

The role of polymorphisms within paraoxonases (192 Gln/Arg in PON1 and 311Ser/Cys in PON2) in the modulation of cardiovascular risk: a pilot study

scientific article published on 24 November 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

16 November 2017

The role of polymorphisms within paraoxonases (192 Gln/Arg in PON1 and 311Ser/Cys in PON2) in the modulation of cardiovascular risk: a pilot study (English)

1 reference

Europe PubMed Central

16 November 2017

3

object named as

Maciej Banach

1 reference

Europe PubMed Central

16 November 2017

5

object named as

Jacek Rysz

1 reference

Europe PubMed Central

16 November 2017

Anna Gluba-Brzózka

1

object named as

Anna Gluba

1 reference

Europe PubMed Central

16 November 2017

Tadeusz Pietrucha

2

object named as

Tadeusz Pietrucha

1 reference

Europe PubMed Central

16 November 2017

author name string

Grzegorz Piotrowski

4

1 reference

Europe PubMed Central

16 November 2017

publication date

24 November 2009

1 reference

Europe PubMed Central

16 November 2017

1 reference

Europe PubMed Central

16 November 2017

61

1 reference

Europe PubMed Central

16 November 2017

157-165

1 reference

Europe PubMed Central

16 November 2017

2

1 reference

Europe PubMed Central

16 November 2017

Paraoxonase-2 is a ubiquitously expressed protein with antioxidant properties and is capable of preventing cell-mediated oxidative modification of low density lipoprotein

1 reference

https://api.crossref.org/works/10.1177%2F0003319709351258

21 January 2018

Asociación de los polimorfismos de la paraoxonasa 1 y la paraoxonasa 2 con el riesgo de infarto agudo de miocardio

1 reference

https://api.crossref.org/works/10.1177%2F0003319709351258

21 January 2018

DNA polymorphisms in two paraoxonase genes (PON1 and PON2) are associated with the risk of coronary heart disease

1 reference

https://api.crossref.org/works/10.1177%2F0003319709351258

21 January 2018

Low paraoxonase activity predicts coronary events in the Caerphilly Prospective Study

1 reference

https://api.crossref.org/works/10.1177%2F0003319709351258

21 January 2018

Protective effect of high density lipoprotein associated paraoxonase. Inhibition of the biological activity of minimally oxidized low density lipoprotein

1 reference

https://api.crossref.org/works/10.1177%2F0003319709351258

21 January 2018

Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase

1 reference

https://api.crossref.org/works/10.1177%2F0003319709351258

21 January 2018

Human paraoxonase gene cluster polymorphisms as predictors of coronary heart disease risk in the prospective Northwick Park Heart Study II.

1 reference

https://api.crossref.org/works/10.1177%2F0003319709351258

21 January 2018

The catalytic histidine dyad of high density lipoprotein-associated serum paraoxonase-1 (PON1) is essential for PON1-mediated inhibition of low density lipoprotein oxidation and stimulation of macrophage cholesterol efflux

1 reference

https://api.crossref.org/works/10.1177%2F0003319709351258

21 January 2018

The effect of the human serum paraoxonase polymorphism is reversed with diazoxon, soman and sarin

1 reference

https://api.crossref.org/works/10.1177%2F0003319709351258

21 January 2018

Serum paraoxonase polymorphism in three populations of southeast Asia

1 reference

https://api.crossref.org/works/10.1177%2F0003319709351258

21 January 2018

Relationship of age-related myocardial infarction risk and Gln/Arg 192 variants of the human paraoxonase1 gene: the REGICOR study

1 reference

https://api.crossref.org/works/10.1177%2F0003319709351258

21 January 2018

Smoking is associated with reduced serum paraoxonase activity and concentration in patients with coronary artery disease.

1 reference

https://api.crossref.org/works/10.1177%2F0003319709351258

21 January 2018

Paraoxonase1-192 polymorphism modulates the nonfatal myocardial infarction risk associated with decreased HDLs

1 reference

https://api.crossref.org/works/10.1177%2F0003319709351258

21 January 2018

A polymorphism of the paraoxonase gene associated with variation in plasma lipoproteins in a genetic isolate.

1 reference

https://api.crossref.org/works/10.1177%2F0003319709351258

21 January 2018

PON2 gene variants are associated with clinical manifestations of cardiovascular disease in familial hypercholesterolemia patients

1 reference

https://api.crossref.org/works/10.1177%2F0003319709351258

21 January 2018

A coronary heart disease risk score based on patient-reported information

1 reference

https://api.crossref.org/works/10.1177%2F0003319709351258

21 January 2018

The Gln-Arg191 polymorphism of the human paraoxonase gene (HUMPONA) is not associated with the risk of coronary artery disease in Finns

1 reference

https://api.crossref.org/works/10.1177%2F0003319709351258

21 January 2018

Indications that paraoxonase-1 contributes to plasma high density lipoprotein levels in familial hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1177%2F0003319709351258

21 January 2018

Combined serum paraoxonase knockout/apolipoprotein E knockout mice exhibit increased lipoprotein oxidation and atherosclerosis

1 reference

https://api.crossref.org/works/10.1177%2F0003319709351258

21 January 2018

Association between the severity of angiographic coronary artery disease and paraoxonase gene polymorphisms in the National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation (WISE) study

1 reference

https://api.crossref.org/works/10.1177%2F0003319709351258

21 January 2018

Oxidative stress increases the expression of the CD36 scavenger receptor and the cellular uptake of oxidized low-density lipoprotein in macrophages from atherosclerotic mice: protective role of antioxidants and of paraoxonase

1 reference

https://api.crossref.org/works/10.1177%2F0003319709351258

21 January 2018

Human serum paraoxonase 1 decreases macrophage cholesterol biosynthesis: possible role for its phospholipase-A2-like activity and lysophosphatidylcholine formation

1 reference

https://api.crossref.org/works/10.1177%2F0003319709351258

21 January 2018

Paraoxonase 1 (PON1) enhances HDL-mediated macrophage cholesterol efflux via the ABCA1 transporter in association with increased HDL binding to the cells: a possible role for lysophosphatidylcholine

1 reference

https://api.crossref.org/works/10.1177%2F0003319709351258

21 January 2018

The correlation of paraoxonase (PON1) activity with lipid and lipoprotein levels differs with vascular disease status

1 reference

https://api.crossref.org/works/10.1177%2F0003319709351258

21 January 2018

Paraoxonase genotypes, lipoprotein lipase activity, and HDL.

1 reference

https://api.crossref.org/works/10.1177%2F0003319709351258

21 January 2018

Paraoxonase 1 overexpression in mice and its effect on high-density lipoproteins

1 reference

https://api.crossref.org/works/10.1177%2F0003319709351258

21 January 2018

HDL: the metabolism, function, and therapeutic importance

1 reference

https://api.crossref.org/works/10.1177%2F0003319709351258

21 January 2018

Parental history of myocardial infarction: lipid traits, gene polymorphisms and lifestyle

1 reference

https://api.crossref.org/works/10.1177%2F0003319709351258

21 January 2018

A prospective study of parental history of myocardial infarction and coronary artery disease in men.

1 reference

https://api.crossref.org/works/10.1177%2F0003319709351258

21 January 2018

The Arg allele in position 192 of PON1 is associated with carotid atherosclerosis in subjects with elevated HDLs

1 reference

https://api.crossref.org/works/10.1177%2F0003319709351258

21 January 2018

Alterations in the high density lipoprotein phenotype and HDL-associated enzymes in subjects with metabolic syndrome.

1 reference

https://api.crossref.org/works/10.1177%2F0003319709351258

21 January 2018

Multiple actions of high-density lipoprotein

1 reference

https://api.crossref.org/works/10.1177%2F0003319709351258

21 January 2018

Myocardial infarction redefined—A consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction

1 reference

https://api.crossref.org/works/10.1177%2F0003319709351258

21 January 2018

Identifiers

10.1177/0003319709351258

1 reference

Europe PubMed Central

16 November 2017

1 reference

Europe PubMed Central

16 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43235426&oldid=1984427254"